$MGTX
MeiraGTx Holdings plc

2021 Q4 Form 10-K Financial Statement

#000155837022003302 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $21.04M $37.70M $3.790M
YoY Change 455.22% 142.25% -45.39%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.55M $43.77M $12.01M
YoY Change 29.48% -1.01% -19.23%
% of Gross Profit
Research & Development $13.62M $67.13M $5.000M
YoY Change 172.32% 97.96% 24.38%
% of Gross Profit
Depreciation & Amortization $2.062M $7.873M $1.350M
YoY Change 52.74% 88.71% 101.49%
% of Gross Profit
Operating Expenses $29.17M $110.9M $17.01M
YoY Change 71.47% 41.96% 37.29%
Operating Profit -$73.19M
YoY Change 17.01%
Interest Expense -$1.752M $288.0K $2.790M
YoY Change -162.8% 107.19% 615.38%
% of Operating Profit
Other Income/Expense, Net -$36.00K -$148.0K -$40.00K
YoY Change -10.0% 5.71%
Pretax Income -$9.912M -$79.56M -$10.46M
YoY Change -5.24% 37.19% 107.13%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.912M -$79.56M -$10.46M
YoY Change -5.24% 37.19% 90.88%
Net Earnings / Revenue -47.1% -211.03% -275.99%
Basic Earnings Per Share -$1.80
Diluted Earnings Per Share -$223.9K -$1.80 -$261.0K
COMMON SHARES
Basic Shares Outstanding 44.45M 44.14M 38.41M
Diluted Shares Outstanding 44.14M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.7M $137.7M $209.5M
YoY Change -34.27% -34.27% -7.79%
Cash & Equivalents $137.7M $137.7M $209.5M
Short-Term Investments
Other Short-Term Assets $2.420M $10.52M $4.565M
YoY Change -46.99% -10.07% 131.66%
Inventory
Prepaid Expenses $8.102M $7.082M
Receivables $22.38M $22.38M $38.50M
Other Receivables $12.63M $12.63M $12.90M
Total Short-Term Assets $183.2M $183.2M $272.6M
YoY Change -32.77% -32.78% 1.34%
LONG-TERM ASSETS
Property, Plant & Equipment $75.86M $126.3M $44.04M
YoY Change 72.24% 44.99% 84.6%
Goodwill
YoY Change
Intangibles $1.791M $2.119M
YoY Change -15.48%
Long-Term Investments $6.656M $6.656M
YoY Change
Other Assets $1.404M $1.404M $1.026M
YoY Change 36.84% 40.4% 426.01%
Total Long-Term Assets $136.9M $136.9M $91.12M
YoY Change 50.26% 50.3% 65.95%
TOTAL ASSETS
Total Short-Term Assets $183.2M $183.2M $272.6M
Total Long-Term Assets $136.9M $136.9M $91.12M
Total Assets $320.2M $320.2M $363.7M
YoY Change -11.97% -11.97% 12.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.35M $15.35M $7.134M
YoY Change 115.14% 116.17% 89.77%
Accrued Expenses $27.59M $30.96M $20.86M
YoY Change 32.24% 32.31% 15.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.13M $68.13M $54.15M
YoY Change 25.82% 25.93% 10.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $66.44M $66.44M $70.80M
YoY Change -6.16% -6.16% -15.41%
Total Long-Term Liabilities $66.44M $66.44M $70.80M
YoY Change -6.16% -6.16% -15.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.13M $68.13M $54.15M
Total Long-Term Liabilities $66.44M $66.44M $70.80M
Total Liabilities $134.8M $134.8M $125.1M
YoY Change 7.69% 7.72% -5.97%
SHAREHOLDERS EQUITY
Retained Earnings -$340.6M -$261.0M
YoY Change 30.48% 28.56%
Common Stock $2.000K $2.000K
YoY Change 0.0% 39.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $185.4M $185.4M $238.6M
YoY Change
Total Liabilities & Shareholders Equity $320.2M $320.2M $363.7M
YoY Change -11.97% -11.97% 12.29%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$9.912M -$79.56M -$10.46M
YoY Change -5.24% 37.19% 90.88%
Depreciation, Depletion And Amortization $2.062M $7.873M $1.350M
YoY Change 52.74% 88.71% 101.49%
Cash From Operating Activities $18.83M -$10.50M -$29.56M
YoY Change -163.69% -83.59% 34.49%
INVESTING ACTIVITIES
Capital Expenditures -$24.37M $46.35M -$10.14M
YoY Change 140.33% 121.52% 113.47%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$15.37M -$90.00K
YoY Change 1011.11% 9.99% -76.92%
Cash From Investing Activities -$25.37M -$61.72M -$10.23M
YoY Change 147.99% 66.71% 99.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.295M 1.708M 69.44M
YoY Change -98.14% -97.94% 14995.65%
NET CHANGE
Cash From Operating Activities 18.83M -10.50M -29.56M
Cash From Investing Activities -25.37M -61.72M -10.23M
Cash From Financing Activities 1.295M 1.708M 69.44M
Net Change In Cash -5.246M -70.51M 29.65M
YoY Change -117.69% 286.16% -211.22%
FREE CASH FLOW
Cash From Operating Activities $18.83M -$10.50M -$29.56M
Capital Expenditures -$24.37M $46.35M -$10.14M
Free Cash Flow $43.20M -$56.85M -$19.42M
YoY Change -322.44% -33.03% 12.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2021Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44139655
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37724189
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001735438
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44189150
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44548925
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.80
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.54
CY2020Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2020Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#Liabilities
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44042000
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38520
CY2021 dei Entity Registrant Name
EntityRegistrantName
MEIRAGTX HOLDINGS PLC
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1448305
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
450 East 29th Street
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
14th Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
CY2021 dei City Area Code
CityAreaCode
646
CY2021 dei Local Phone Number
LocalPhoneNumber
860-7985
CY2021 dei Security12b Title
Security12bTitle
Ordinary Shares, $0.00003881 par value per share
CY2021 dei Trading Symbol
TradingSymbol
MGTX
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
458612481
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44677614
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Jericho, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137703000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
209520000
CY2021Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
22384000
CY2020Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
38479000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8102000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7082000
CY2021Q4 mgtx Tax Incentive Receivable
TaxIncentiveReceivable
12634000
CY2020Q4 mgtx Tax Incentive Receivable
TaxIncentiveReceivable
12930000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2420000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4565000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
183243000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
272576000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75860000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44042000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1791000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2119000
CY2021Q4 mgtx In Process Research And Development
InProcessResearchAndDevelopment
783000
CY2020Q4 mgtx In Process Research And Development
InProcessResearchAndDevelopment
852000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1404000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1026000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
6656000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22782000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21486000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27645000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
21596000
CY2021Q4 us-gaap Assets
Assets
320164000
CY2020Q4 us-gaap Assets
Assets
363697000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15348000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7134000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27586000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20861000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3374000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2583000
CY2021Q4 mgtx Deferred Revenue Related Party Current
DeferredRevenueRelatedPartyCurrent
21820000
CY2020Q4 mgtx Deferred Revenue Related Party Current
DeferredRevenueRelatedPartyCurrent
23545000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
24000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68128000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
54147000
CY2021Q4 mgtx Deferred Revenue Related Party Noncurrent
DeferredRevenueRelatedPartyNoncurrent
43046000
CY2020Q4 mgtx Deferred Revenue Related Party Noncurrent
DeferredRevenueRelatedPartyNoncurrent
49297000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20359000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19666000
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2081000
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1814000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
196000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
214000
CY2021Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
953000
CY2021Q4 us-gaap Liabilities
Liabilities
134763000
CY2020Q4 us-gaap Liabilities
Liabilities
125138000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00003881
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00003881
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1288327750
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1288327750
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44548925
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44189150
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
528659000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
504482000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2671000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4897000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340589000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-261028000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185401000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
238559000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
320164000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
363697000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37701000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15563000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43765000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44207000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
67128000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33910000
CY2021 us-gaap Operating Expenses
OperatingExpenses
110893000
CY2020 us-gaap Operating Expenses
OperatingExpenses
78117000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-73192000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-62554000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6293000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3426000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
212000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1275000
CY2021 us-gaap Interest Expense
InterestExpense
288000
CY2020 us-gaap Interest Expense
InterestExpense
139000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-79561000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57992000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2226000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3103000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77335000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61095000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79561000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57992000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.80
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.54
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44139655
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37724189
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
190801000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
841000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18417000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3103000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57992000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
238559000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1709000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20784000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2226000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-79561000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185401000
CY2021 us-gaap Profit Loss
ProfitLoss
-79561000
CY2020 us-gaap Profit Loss
ProfitLoss
-57992000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
20784000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
18417000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6293000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3426000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7873000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4172000
CY2021 mgtx Operating Leases Expenses
OperatingLeasesExpenses
161000
CY2020 mgtx Operating Leases Expenses
OperatingLeasesExpenses
-387000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-213000
CY2020 mgtx Gain Loss On Termination Of Lease Liability
GainLossOnTerminationOfLeaseLiability
144000
CY2021 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-9000
CY2021 mgtx Amortization Of Interest On Asset Retirement Obligation
AmortizationOfInterestOnAssetRetirementObligation
148000
CY2020 mgtx Amortization Of Interest On Asset Retirement Obligation
AmortizationOfInterestOnAssetRetirementObligation
136000
CY2021 mgtx Shares Issued In Connection With License Agreement
SharesIssuedInConnectionWithLicenseAgreement
976000
CY2021 mgtx Research And Development Expenses Settled By Shares Issuance
ResearchAndDevelopmentExpensesSettledBySharesIssuance
1020000
CY2020 mgtx Research And Development Expenses Settled By Shares Issuance
ResearchAndDevelopmentExpensesSettledBySharesIssuance
7685000
CY2021 mgtx Change In Acquisition Liability
ChangeInAcquisitionLiability
434000
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-16391000
CY2020 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
15402000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1083000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2366000
CY2021 mgtx Increase Decrease In Tax Incentive Receivables
IncreaseDecreaseInTaxIncentiveReceivables
-310000
CY2020 mgtx Increase Decrease In Tax Incentive Receivables
IncreaseDecreaseInTaxIncentiveReceivables
715000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2161000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2520000
CY2021 mgtx Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
457000
CY2020 mgtx Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
-164000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13347000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1566000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8118000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2171000
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-23000
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
24000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7487000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-15563000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10530000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63967000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46351000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20924000
CY2021 mgtx Payments For Right Of Use Asset
PaymentsForRightOfUseAsset
8866000
CY2020 mgtx Payments For Right Of Use Asset
PaymentsForRightOfUseAsset
13968000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2128000
CY2021 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
6500000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61717000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37020000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
23000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1709000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
841000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
87051000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5141000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1708000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82728000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-70539000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18259000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1278000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
422000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209520000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227357000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137703000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209520000
CY2021 mgtx Stock Issued Under License Agreement
StockIssuedUnderLicenseAgreement
1165000
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
7178000
CY2020 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1615000
CY2021 mgtx Lease Obligations In Exchange Of Right Of Use Assets
LeaseObligationsInExchangeOfRightOfUseAssets
-4424000
CY2020 mgtx Lease Obligations In Exchange Of Right Of Use Assets
LeaseObligationsInExchangeOfRightOfUseAssets
-1889000
CY2021 us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
120000
CY2021 us-gaap Stock Issued1
StockIssued1
519000
CY2020 us-gaap Stock Issued1
StockIssued1
7685000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
139000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-340600000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10500000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137700000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 18pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements if these results differ from historical experience, or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. In preparing these consolidated financial statements, management used significant estimates in the following areas, among others: collaboration revenue, the accounting for research and development costs, share-based compensation, leases, asset retirement obligations and tax incentive receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">Additionally, the Company has made estimates of the impact of the COVID-19 pandemic within the consolidated financial statements and there may be changes to those estimates in future periods. Actual results may differ from these estimates.</p>
CY2021Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
1500000
CY2021Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
1500000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 18pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 18pt;">The Company maintains its cash and cash equivalents primarily in depository and money market accounts within two large financial institutions in the United States and one large financial institution in the United Kingdom and Ireland.  Cash balances deposited at these major financial banking institutions exceed the insured limit. The Company has not experienced any losses on its bank deposits and believes these deposits do not expose the Company to any significant credit risk.</p>
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
6656000
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1814000
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1655000
CY2021 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
120000
CY2021 mgtx Amortization Of Interest On Asset Retirement Obligation
AmortizationOfInterestOnAssetRetirementObligation
148000
CY2020 mgtx Amortization Of Interest On Asset Retirement Obligation
AmortizationOfInterestOnAssetRetirementObligation
136000
CY2021 us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
-1000
CY2020 us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
23000
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2081000
CY2020Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1814000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
700000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
500000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7512787
CY2021Q4 mgtx Long Term Investments Cost Basis
LongTermInvestmentsCostBasis
6665000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5659771
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
136921000
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
91121000
CY2020Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
7700000
CY2021Q4 mgtx Other Investment Ownership Percentage
OtherInvestmentOwnershipPercentage
0.03
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2903000
CY2021Q4 mgtx Prepaid Dues And License Fees
PrepaidDuesAndLicenseFees
1185000
CY2020Q4 mgtx Prepaid Dues And License Fees
PrepaidDuesAndLicenseFees
515000
CY2021Q4 mgtx Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
991000
CY2020Q4 mgtx Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
164000
CY2021Q4 mgtx Prepaid Manufacturing Costs Current
PrepaidManufacturingCostsCurrent
624000
CY2020Q4 mgtx Prepaid Manufacturing Costs Current
PrepaidManufacturingCostsCurrent
1395000
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
455000
CY2020Q4 us-gaap Prepaid Rent
PrepaidRent
169000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
403000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
311000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8102000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7082000
CY2021Q4 mgtx Prepaid Clinical Trial Cost
PrepaidClinicalTrialCost
2322000
CY2020Q4 mgtx Prepaid Clinical Trial Cost
PrepaidClinicalTrialCost
1625000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2122000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90339000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52429000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14479000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8387000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75860000
CY2019Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4100000
CY2021 mgtx Asset Retirement Obligations Discounted Rate
AssetRetirementObligationsDiscountedRate
0.08
CY2021 us-gaap Depreciation
Depreciation
6300000
CY2020 us-gaap Depreciation
Depreciation
3700000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20000.00
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
306000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
306000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
306000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
306000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
306000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
261000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1791000
CY2021Q4 mgtx Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
12524000
CY2020Q4 mgtx Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
10261000
CY2021Q4 mgtx Accrued Liabilities Accrued Compensation And Benefits
AccruedLiabilitiesAccruedCompensationAndBenefits
6029000
CY2020Q4 mgtx Accrued Liabilities Accrued Compensation And Benefits
AccruedLiabilitiesAccruedCompensationAndBenefits
3791000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27586000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20861000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
186638
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.16
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
381143
CY2021Q4 mgtx Accrued Liabilities Accrued Manufacturing Costs Expense
AccruedLiabilitiesAccruedManufacturingCostsExpense
2889000
CY2020Q4 mgtx Accrued Liabilities Accrued Manufacturing Costs Expense
AccruedLiabilitiesAccruedManufacturingCostsExpense
1886000
CY2021Q4 mgtx Accrued Expenses Incurred In Connection With Fixed Assets
AccruedExpensesIncurredInConnectionWithFixedAssets
2077000
CY2020Q4 mgtx Accrued Expenses Incurred In Connection With Fixed Assets
AccruedExpensesIncurredInConnectionWithFixedAssets
949000
CY2021Q4 mgtx Accrued Research And Development
AccruedResearchAndDevelopment
1735000
CY2020Q4 mgtx Accrued Research And Development
AccruedResearchAndDevelopment
893000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1018000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1219000
CY2021Q4 mgtx Accrued Consulting Expenses
AccruedConsultingExpenses
858000
CY2020Q4 mgtx Accrued Consulting Expenses
AccruedConsultingExpenses
1047000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
456000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
815000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3054996
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7388448
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1195477
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1778500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3645360
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.31
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1666500
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.91
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
109296
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.69
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
377793
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.71
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4824771
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.85
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M1D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1667700
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.53
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.22
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5924690
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.16
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3275644
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.95
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M23D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
62702
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
41884
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
14400000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8200000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20784000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18417000
CY2020 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2021 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.44
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.87
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
6800000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
6700000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36957000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15788000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
36957000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15788000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79561000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57992000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
74007000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
43831000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10314000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5392000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7498000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
5819000
CY2021Q4 mgtx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
7040000
CY2020Q4 mgtx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
6150000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1481000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
298000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100340000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
61490000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
196000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
173000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3339000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2252000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6733000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5929000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
90268000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
513000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
165000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53311000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
196000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
175000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
700000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
500000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
138000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
12000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
375000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
666000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
513000
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
5000000.0
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
3300000
CY2021 mgtx Annual Lease Cost And Annual Maintenance Fees
AnnualLeaseCostAndAnnualMaintenanceFees
300000
CY2021 mgtx Annual Lease Cost And Annual Maintenance Fees
AnnualLeaseCostAndAnnualMaintenanceFees
400000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1227000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
519000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
CY2021 mgtx Finance Lease Cost
FinanceLeaseCost
1229000
CY2020 mgtx Finance Lease Cost
FinanceLeaseCost
522000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5002000
CY2020 mgtx Finance Lease Payments
FinanceLeasePayments
3000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
3423000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
751000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
714000
CY2021 us-gaap Lease Cost
LeaseCost
6982000
CY2020 us-gaap Lease Cost
LeaseCost
4659000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22782000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21486000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
23721000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
22221000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27645000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
21596000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
12000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
28000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P176Y8M12D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P175Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.086
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
16000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
22000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
4969000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3791000
CY2021 mgtx Finance Lease Payments
FinanceLeasePayments
2000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4424000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1889000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5252000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
13000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5382000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5223000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5226000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4996000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4251000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
30330000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
13000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6609000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
1000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
23721000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
12000
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1800000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1100000

Files In Submission

Name View Source Status
0001558370-22-003302-index-headers.html Edgar Link pending
0001558370-22-003302-index.html Edgar Link pending
0001558370-22-003302.txt Edgar Link pending
0001558370-22-003302-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgtx-20211231.xsd Edgar Link pending
mgtx-20211231x10k.htm Edgar Link pending
mgtx-20211231x10k006.jpg Edgar Link pending
mgtx-20211231x10k_htm.xml Edgar Link completed
mgtx-20211231xex10d26.htm Edgar Link pending
mgtx-20211231xex10d35.htm Edgar Link pending
mgtx-20211231xex10d36.htm Edgar Link pending
mgtx-20211231xex21.htm Edgar Link pending
mgtx-20211231xex23d1.htm Edgar Link pending
mgtx-20211231xex31d1.htm Edgar Link pending
mgtx-20211231xex31d2.htm Edgar Link pending
mgtx-20211231xex32d1.htm Edgar Link pending
mgtx-20211231xex32d2.htm Edgar Link pending
mgtx-20211231_cal.xml Edgar Link unprocessable
mgtx-20211231_def.xml Edgar Link unprocessable
mgtx-20211231_lab.xml Edgar Link unprocessable
mgtx-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending